World Health Organization site
Skip Navigation Links
Advanced Search
List ByExpand List By
Search Tips
ICTRP websiteExpand ICTRP website
Contact us
                   236 records for 81 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
  Showrecords per page     

1 2 3 4 5 6 7 8 9
Recruitment statusMain ID Public TitleDate of Registration
Not recruitingNCT02406092
Safety Study of Rituximab
An Observational Study in Differentiated Thyroid Cancer Which is Radioactive Iodine (RAI) Refractory to Assess the Use of Multikinase Inhibitors
A clinical trial evaluating tumour marker-driven treatment choices for advanced colorectal cancer. 11/09/2014
Hyperion™ International Registry Trial
Afatinib as second-line therapy for lung cancer with EGFR mutation
Recruitment statusMain IDPublic titleDate of registration
RecruitingNCT02208843Afatinib as Second-line Therapy for Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutation04/08/2014
Multicentric, Transversal, Descriptive, Epidemiological Study on the Management of Asthma in Asthmatic Middle East Adult Population
Treatment of Venous Thromboembolism (VTE) With Either Rivaroxaban or Current Standard of Care Therapy
Study to to evaluate the occurrence of Myeloproliferative neoplasm (a type of disease in which the bone marrow makes too many RBC, platelets, or certain WBC) & to characterize treatment patterns & burden/ symptoms of illness under routine medical practice
Safety and Efficacy of Nonacog Beta Pegol (N9-GP) in Previously Untreated Patients With Haemophilia B
Recruitment statusMain IDPublic titleDate of registration
AuthorisedEUCTR2012-004867-38-ESSafety and Efficacy of nonacog beta pegol (N9-GP) in Previously Untreated Patients with Haemophilia B10/07/2015
AuthorisedEUCTR2012-004867-38-GBSafety and Efficacy of nonacog beta pegol (N9-GP) in Previously Untreated Patients with Haemophilia B 09/06/2015
Not RecruitingCTRI/2014/03/004443
A clinical study of EVERolimus (RAD001)in combination with EXemestane in post-menopausal women with EStrogen receptor positive, human epidermal growth factor receptor 2 negative locally advanced or metastatic breast cancer
1 2 3 4 5 6 7 8 9
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.2 - Version history